| Literature DB >> 19758683 |
Lisa F Newcomb1, James D Brooks, Peter R Carroll, Ziding Feng, Martin E Gleave, Peter S Nelson, Ian M Thompson, Daniel W Lin.
Abstract
Active surveillance is a management plan for localized prostate cancer that offers selective delayed intervention on indication of disease progression, allowing patients to delay or avoid treatment and associated side-effects. Outcomes from centers that promote active surveillance are favorable, with high rates of disease-specific survival. However, there remains a need for prognostic variables or biomarkers that distinguish with high specificity the aggressive cancers that progress on surveillance from the indolent cancers. The Canary Prostate Active Surveillance Study is a multicenter study and a biorepository that will discover and confirm biomarkers of aggressive disease as defined by histologic, prostate-specific antigen, or clinical criteria. 2010 Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19758683 PMCID: PMC3827723 DOI: 10.1016/j.urology.2009.05.050
Source DB: PubMed Journal: Urology ISSN: 0090-4295 Impact factor: 2.649